191 related articles for article (PubMed ID: 33416119)
1. Fangchinoline exerts antitumour activity by suppressing the EGFR‑PI3K/AKT signalling pathway in colon adenocarcinoma.
Jiang F; Ren S; Chen Y; Zhang A; Zhu Y; Zhang Z; Li Z; Piao D
Oncol Rep; 2021 Jan; 45(1):139-150. PubMed ID: 33416119
[TBL] [Abstract][Full Text] [Related]
2. Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1‑AKT/ERK‑Snail signaling pathway.
Jiang F; Chen Y; Ren S; Li Z; Sun K; Xing Y; Zhu Y; Piao D
Int J Oncol; 2020 Jul; 57(1):183-196. PubMed ID: 32319595
[TBL] [Abstract][Full Text] [Related]
3. Fraxetin inhibits the growth of colon adenocarcinoma cells via the Janus kinase 2/signal transducer and activator of transcription 3 signalling pathway.
Ren S; Xing Y; Wang C; Jiang F; Liu G; Li Z; Jiang T; Zhu Y; Piao D
Int J Biochem Cell Biol; 2020 Aug; 125():105777. PubMed ID: 32504672
[TBL] [Abstract][Full Text] [Related]
4. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
[TBL] [Abstract][Full Text] [Related]
5. Fangchinoline suppresses the proliferation, invasion and tumorigenesis of human osteosarcoma cells through the inhibition of PI3K and downstream signaling pathways.
Li X; Yang Z; Han W; Lu X; Jin S; Yang W; Li J; He W; Qian Y
Int J Mol Med; 2017 Aug; 40(2):311-318. PubMed ID: 28586029
[TBL] [Abstract][Full Text] [Related]
6. Fangchinoline derivatives inhibits PI3K signaling in vitro and in vivo in non-small cell lung cancer.
Chen JS; Guo X; Sun JY; Wang MX; Gao XZ; Wang Z; Han JL; Sun H; Zhang K; Liu C
Bioorg Chem; 2023 Sep; 138():106623. PubMed ID: 37295240
[TBL] [Abstract][Full Text] [Related]
7. Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells.
Tian F; Ding D; Li D
Int J Oncol; 2015; 46(6):2355-63. PubMed ID: 25872479
[TBL] [Abstract][Full Text] [Related]
8. Rotenone restrains the proliferation, motility and epithelial-mesenchymal transition of colon cancer cells and the tumourigenesis in nude mice via PI3K/AKT pathway.
Xue W; Men S; Liu R
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1484-1494. PubMed ID: 32282954
[TBL] [Abstract][Full Text] [Related]
9. RecQ-like helicase 4 (RECQL4) exacerbates resistance to oxaliplatin in colon adenocarcinoma via activation of the PI3K/AKT signaling pathway.
Zhou F; Wang L; Jin K; Wu Y
Bioengineered; 2021 Dec; 12(1):5859-5869. PubMed ID: 34477047
[TBL] [Abstract][Full Text] [Related]
10. Fangchinoline exerts anticancer effects on colorectal cancer by inducing autophagy via regulation AMPK/mTOR/ULK1 pathway.
Xiang X; Tian Y; Hu J; Xiong R; Bautista M; Deng L; Yue Q; Li Y; Kuang W; Li J; Liu K; Yu C; Feng G
Biochem Pharmacol; 2021 Apr; 186():114475. PubMed ID: 33609560
[TBL] [Abstract][Full Text] [Related]
11. Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.
Li J; Cen W; Tong C; Wang L; Zhang W; Deng S; Yu J; Lu B
PLoS One; 2022; 17(4):e0266738. PubMed ID: 35446864
[TBL] [Abstract][Full Text] [Related]
12. CXCL8 induces epithelial-mesenchymal transition in colon cancer cells via the PI3K/Akt/NF-κB signaling pathway.
Shen T; Yang Z; Cheng X; Xiao Y; Yu K; Cai X; Xia C; Li Y
Oncol Rep; 2017 Apr; 37(4):2095-2100. PubMed ID: 28259918
[TBL] [Abstract][Full Text] [Related]
13. Fangchinoline inhibits cell proliferation via Akt/GSK-3beta/ cyclin D1 signaling and induces apoptosis in MDA-MB-231 breast cancer cells.
Wang CD; Yuan CF; Bu YQ; Wu XM; Wan JY; Zhang L; Hu N; Liu XJ; Zu Y; Liu GL; Song FZ
Asian Pac J Cancer Prev; 2014; 15(2):769-73. PubMed ID: 24568493
[TBL] [Abstract][Full Text] [Related]
14. Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K/AKT and NF-κB/iNOS signaling pathways.
Gao Y; Xiao X; Zhang C; Yu W; Guo W; Zhang Z; Li Z; Feng X; Hao J; Zhang K; Xiao B; Chen M; Huang W; Xiong S; Wu X; Deng W
J Pineal Res; 2017 Mar; 62(2):. PubMed ID: 27865009
[TBL] [Abstract][Full Text] [Related]
15. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway.
Yang J; Hu S; Wang C; Song J; Chen C; Fan Y; Ben-David Y; Pan W
Eur J Med Chem; 2020 Jan; 186():111898. PubMed ID: 31784186
[TBL] [Abstract][Full Text] [Related]
16. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
17. Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway.
Liu Y; Lv H; Li X; Liu J; Chen S; Chen Y; Jin Y; An R; Yu S; Wang Z
Int J Biol Sci; 2021; 17(13):3522-3537. PubMed ID: 34512163
[TBL] [Abstract][Full Text] [Related]
18. Deoxyshikonin isolated from
Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
[No Abstract] [Full Text] [Related]
19. Cotargeting of epidermal growth factor receptor and PI3K overcomes PI3K-Akt oncogenic dependence in pancreatic ductal adenocarcinoma.
Wong MH; Xue A; Julovi SM; Pavlakis N; Samra JS; Hugh TJ; Gill AJ; Peters L; Baxter RC; Smith RC
Clin Cancer Res; 2014 Aug; 20(15):4047-58. PubMed ID: 24895459
[TBL] [Abstract][Full Text] [Related]
20. ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway.
Xing Y; Ren S; Ai L; Sun W; Zhao Z; Jiang F; Zhu Y; Piao D
Int J Oncol; 2019 May; 54(5):1691-1703. PubMed ID: 30816443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
